Kamada Ltd
NASDAQ:KMDA
Kamada Ltd
Inventory
Kamada Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Inventory
$85.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
|
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Inventory
$8.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pluri Inc
NASDAQ:PLUR
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Matricelf Ltd
TASE:MTLF
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
Glance View
Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
See Also
What is Kamada Ltd's Inventory?
Inventory
85.4m
USD
Based on the financial report for Sep 30, 2025, Kamada Ltd's Inventory amounts to 85.4m USD.
What is Kamada Ltd's Inventory growth rate?
Inventory CAGR 10Y
12%
Over the last year, the Inventory growth was 19%. The average annual Inventory growth rates for Kamada Ltd have been 5% over the past three years , 15% over the past five years , and 12% over the past ten years .
